VI
PRCT icon

Versor Investments’s Procept Biorobotics PRCT Stock Holding History

Versor Investments’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,228
Closed -$205K – 791
2023
Q1 		$205K Buy
7,228
+231
+3% +$8.15K 0.03% 631
2022
Q4 		$291K Buy
+6,997
New +$300K 0.03% 524

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Versor Investments's PRCT Position: Q2 2023 in Review

Versor Investments sold out of Procept Biorobotics (PRCT) in Q2 2023, closing a stake of 7,228 shares — an estimated $205K sold.

Versor Investments first reported a position in PRCT in Q4 2022 and held it in 2 quarters. The position peaked at $291K in Q4 2022. 120 funds tracked by Wall St. Rank hold PRCT as of Q2 2023.

  • Versor Investments reported no remaining Procept Biorobotics position as of Q2 2023 after selling out during the quarter.
  • Versor Investments sold 7,228 Procept Biorobotics shares in Q2 2023, an estimated $205K.
  • Versor Investments first reported a position in Procept Biorobotics in Q4 2022 and held it in 2 quarters.
  • Versor Investments's Procept Biorobotics position peaked at $291K in Q4 2022.
  • 120 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2023.

Based on Versor Investments's 13F filing for Q2 2023, filed 7 Aug 2023.